Medicover AB Series B
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more
Medicover AB Series B (0RPS) - Total Assets
Latest total assets as of June 2025: Skr2.32 Billion SEK
Based on the latest financial reports, Medicover AB Series B (0RPS) holds total assets worth Skr2.32 Billion SEK as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medicover AB Series B - Total Assets Trend (2014–2024)
This chart illustrates how Medicover AB Series B’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medicover AB Series B - Asset Composition Analysis
Current Asset Composition (December 2024)
Medicover AB Series B's total assets of Skr2.32 Billion consist of 20.9% current assets and 79.1% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 3.3% |
| Accounts Receivable | Skr212.40 Million | 9.9% |
| Inventory | Skr69.10 Million | 3.2% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr133.20 Million | 6.2% |
| Goodwill | Skr524.10 Million | 24.5% |
Asset Composition Trend (2014–2024)
This chart illustrates how Medicover AB Series B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medicover AB Series B's current assets represent 20.9% of total assets in 2024, a decrease from 29.8% in 2014.
- Cash Position: Cash and equivalents constituted 3.3% of total assets in 2024, down from 4.4% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, a decrease from 41.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 24.5% of total assets.
Medicover AB Series B Competitors by Total Assets
Key competitors of Medicover AB Series B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Medicover AB Series B - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Medicover AB Series B generates 0.98x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Medicover AB Series B generates $ 0.78 in net profit.
Medicover AB Series B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.87 | 0.80 | 1.36 |
| Quick Ratio | 0.77 | 0.67 | 1.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-68.70 Million | Skr -108.60 Million | Skr 73.10 Million |
Medicover AB Series B - Advanced Valuation Insights
This section examines the relationship between Medicover AB Series B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 10.1% |
| Total Assets | Skr2.14 Billion |
| Market Capitalization | $916.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medicover AB Series B's assets below their book value (0.43 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medicover AB Series B's assets grew by 10.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medicover AB Series B (2014–2024)
The table below shows the annual total assets of Medicover AB Series B from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr2.14 Billion | +10.14% |
| 2023-12-31 | Skr1.94 Billion | +5.98% |
| 2022-12-31 | Skr1.83 Billion | +8.75% |
| 2021-12-31 | Skr1.68 Billion | +51.62% |
| 2020-12-31 | Skr1.11 Billion | +8.97% |
| 2019-12-31 | Skr1.02 Billion | +66.80% |
| 2018-12-31 | Skr611.20 Million | +21.32% |
| 2017-12-31 | Skr503.80 Million | +20.10% |
| 2016-12-31 | Skr419.50 Million | +34.11% |
| 2015-12-31 | Skr312.80 Million | +16.02% |
| 2014-12-31 | Skr269.60 Million | -- |